Anxiety and Substance Use Disorder Treatment in Tampa, FL

Anxiety disorders and substance use disorders co-occur at rates far higher than chance; nearly 30% of people with one will experience the other in their lifetime. The primary connection is self-medication: people with anxiety disorders (generalized anxiety, social anxiety, panic disorder, PTSD, and others) often use alcohol, benzodiazepines, opioids, or other substances to manage anxiety symptoms they cannot otherwise escape. While substances provide temporary relief, chronic use alters the very neurotransmitter systems involved in anxiety regulation, typically worsening anxiety over time and creating a reinforcing cycle in which both conditions worsen simultaneously.

Yes. The ADAA is explicit: treating substance use disorder alone will not resolve an anxiety disorder, and treating anxiety without addressing substance use disorder leaves the primary behavioral driver of substance use untreated. Research and clinical evidence overwhelmingly support integrated treatment addressing both conditions simultaneously with a coordinated clinical team as the standard of care for co-occurring anxiety and substance use disorders. Sequential treatment (one at a time) produces significantly higher relapse rates for both conditions.

Yes, reliably. Alcohol is a central nervous system depressant that can provide short-term sedation of anxiety symptoms, which is exactly why it is so commonly misused by people with anxiety disorders. However, as the body metabolizes alcohol, a rebound effect produces heightened anxiety, often worse than the baseline anxiety the person was drinking to manage. Chronic alcohol use also disrupts sleep architecture, impairs emotional regulation capacity, and alters GABA and glutamate systems central to anxiety regulation. The net effect of regular alcohol use in a person with an anxiety disorder is virtually always an escalation of both the anxiety disorder and the alcohol use over time.

This is one of the most clinically important questions in dual diagnosis treatment, and it requires individualized psychiatric judgment. Benzodiazepines, the most commonly prescribed anxiety medications in general outpatient settings, carry a significant risk of dependence and misuse in people with a substance use disorder history, and are generally avoided during active recovery. Non-addictive first-line options for anxiety in the context of SUD include SSRIs and SNRIs (for GAD, social anxiety, panic disorder, and PTSD), buspirone (for GAD specifically), and certain antidepressants validated for specific anxiety subtypes. At Riverside Recovery, all medication decisions are made by Dr. Michael Sore, MD, with full transparency, informed consent, and ongoing monitoring.

The most extensively validated therapies for co-occurring anxiety and substance use disorder are cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and trauma-focused approaches, including Accelerated Resolution Therapy (ART) for clients with PTSD or trauma histories. ART combines techniques from CBT, psychodynamic therapy, and bilateral eye movement processing to resolve traumatic memories rapidly, typically in fewer sessions than traditional trauma therapies. These are delivered at Riverside Recovery through individual, group, and family therapy, integrated across the treatment continuum.

Dual diagnosis treatment at Riverside begins with a comprehensive psychiatric and clinical assessment at intake conducted by Dr. Michael Sore, MD, and our clinical team that establishes the nature and severity of both the anxiety disorder and the substance use disorder. Treatment is fully integrated: the same clinical team manages both conditions, therapy sessions address both simultaneously, and medication management (where appropriate) is ongoing and coordinated. Anxiety treatment is not a sidebar to addiction treatment at Riverside; it runs through every session, every level of care, and every transition from the beginning of treatment through to discharge and aftercare planning.